Patterns of Neurological Adverse Events Among a Retrospective Cohort of Patients Receiving Immune Checkpoint Inhibitors-Reference-Cited by-同舟云学术

Patterns of Neurological Adverse Events Among a Retrospective Cohort of Patients Receiving Immune Checkpoint Inhibitors

Published:2024-01-10 Issue:6 Volume:16 Page:381-390
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Hunting John C¹^ORCID,Faucheux Andrew T²,Price Sarah N³,Elko Catherine A¹,Quattlebaum Alexander¹,Bloomer Chance¹,Olson Eric²,Petty William J²,Lycan Thomas W²

Affiliation:

1. Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC27157, USA

2. Department of Hematology & Oncology, Wake Forest School of Medicine, Winston-Salem, NC27157, USA

3. Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC27157, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/imt-2023-0273

Reference22 articles.

1. Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review

2. Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysis

3. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

4. Pembrolizumab (Keytruda)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献